NCT03250299 2024-06-24Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaBasilea PharmaceuticaPhase 1 Terminated26 enrolled 17 charts
NCT04642937 2023-01-27Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent GlioblastomaOX2 TherapeuticsPhase 1 Unknown24 enrolled